[Chemotherapy of brain tumors: biological basis of its limited efficacy].
Chemotherapy is often the only treatment for relapse of brain tumors and should increase the survival of patients with gliomas. Although new anticancer drugs have been discovered, the number of active drugs in these tumors is very low. Several biological mechanisms decrease the efficacy of chemotherapy: cellular kinetics, heterogeneity and micro-environment of brain tumors, and the classical blood-brain barrier. Moreover, several mechanisms of chemoresistance, identified in other tumors, should be involved in intrinsic chemoresistance. These biological factors, which are involved simultaneously or successively suggest that the chemotherapy currently used in brain tumors cannot increase the response rate; even if high dose chemotherapy with autologous bone marrow transplantation or intratumor administration of drugs are used.
Mousseau
M
M
Service d'oncologie médicale, hôpital A-Michallon, Grenoble, France.
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D004351:Drug Resistance; D005602:France / Q000453:epidemiology; D005909:Glioblastoma / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D011034:Podophyllotoxin
La chimiothérapie des tumeurs cérébrales: bases biologiques de son efficacité limitée.